Literature DB >> 12414970

The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion.

E Jeetendra1, Clinton S Robison, Lorraine M Albritton, Michael A Whitt.   

Abstract

Recently we showed that the membrane-proximal stem region of the vesicular stomatitis virus (VSV) G protein ectodomain (G stem [GS]), together with the transmembrane and cytoplasmic domains, was sufficient to mediate efficient VSV budding (C. S. Robison and M. A. Whitt, J. Virol. 74:2239-2246, 2000). Here, we show that GS can also potentiate the membrane fusion activity of heterologous viral fusion proteins when GS is coexpressed with those proteins. For some fusion proteins, there was as much as a 40-fold increase in syncytium formation when GS was coexpressed compared to that seen when the fusion protein was expressed alone. Fusion potentiation by GS was not protein specific, since it occurred with both pH-dependent as well as pH-independent fusion proteins. Using a recombinant vesicular stomatitis virus encoding GS that contained an N-terminal hemagglutinin (HA) tag (GS(HA) virus), we found that the GS(HA) virus bound to cells as well as the wild-type virus did at pH 7.0; however, the GS(HA) virus was noninfectious. Analysis of cells expressing GS(HA) in a three-color membrane fusion assay revealed that GS(HA) could induce lipid mixing but not cytoplasmic mixing, indicating that GS can induce hemifusion. Treatment of GS(HA) virus-bound cells with the membrane-destabilizing drug chlorpromazine rescued the hemifusion block and allowed entry and subsequent replication of GS(HA) virus, demonstrating that GS-mediated hemifusion was a functional intermediate in the membrane fusion pathway. Using a series of truncation mutants, we also determined that only 14 residues of GS, together with the VSV G transmembrane and cytoplasmic tail, were sufficient for fusion potentiation. To our knowledge, this is the first report which shows that a small domain of one viral glycoprotein can promote the fusion activity of other, unrelated viral glycoproteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414970      PMCID: PMC136858          DOI: 10.1128/jvi.76.23.12300-12311.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.

Authors:  T Suárez; W R Gallaher; A Agirre; F M Goñi; J L Nieva
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release.

Authors:  H R Jayakar; K G Murti; M A Whitt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  pH-dependent fusion of vesicular stomatitis virus with Vero cells. Measurement by dequenching of octadecyl rhodamine fluorescence.

Authors:  R Blumenthal; A Bali-Puri; A Walter; D Covell; O Eidelman
Journal:  J Biol Chem       Date:  1987-10-05       Impact factor: 5.157

4.  Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates.

Authors:  R E Randall; D F Young; K K Goswami; W C Russell
Journal:  J Gen Virol       Date:  1987-11       Impact factor: 3.891

5.  Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of epitopes.

Authors:  B J Bricker; R M Snyder; J W Fox; W A Volk; R R Wagner
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

6.  Three membrane-proximal amino acids in the human parainfluenza type 2 (HPIV 2) F protein are critical for fusogenic activity.

Authors:  S Tong; F Yi; A Martin; Q Yao; M Li; R W Compans
Journal:  Virology       Date:  2001-02-01       Impact factor: 3.616

7.  Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes.

Authors:  T R Fuerst; P L Earl; B Moss
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

8.  Vesicular stomatitis virus G protein acquires pH-independent fusion activity during transport in a polarized endometrial cell line.

Authors:  P C Roberts; T Kipperman; R W Compans
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

9.  Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.

Authors:  S Matsushita; M Robert-Guroff; J Rusche; A Koito; T Hattori; H Hoshino; K Javaherian; K Takatsuki; S Putney
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  HIV-1 membrane fusion: targets of opportunity.

Authors:  R W Doms; J P Moore
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  37 in total

1.  A capsid protein of nonenveloped Bluetongue virus exhibits membrane fusion activity.

Authors:  Mario Forzan; Christoph Wirblich; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

2.  Crystal structure of the oligomerization domain of the phosphoprotein of vesicular stomatitis virus.

Authors:  Haitao Ding; Todd J Green; Shanyun Lu; Ming Luo
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins.

Authors:  Marija Backovic; George P Leser; Robert A Lamb; Richard Longnecker; Theodore S Jardetzky
Journal:  Virology       Date:  2007-07-25       Impact factor: 3.616

Review 4.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

5.  The pre-transmembrane domain of the Autographa californica multicapsid nucleopolyhedrovirus GP64 protein is critical for membrane fusion and virus infectivity.

Authors:  Zhaofei Li; Gary W Blissard
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

6.  Tracking fusion of human mesenchymal stem cells after transplantation to the heart.

Authors:  Brian T Freeman; Nicholas A Kouris; Brenda M Ogle
Journal:  Stem Cells Transl Med       Date:  2015-04-06       Impact factor: 6.940

7.  SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.

Authors:  Chetan Sood; Mariana Marin; Ajit Chande; Massimo Pizzato; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

8.  Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein.

Authors:  Chad E Mire; Derek Dube; Sue E Delos; Judith M White; Michael A Whitt
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

9.  Prediction and identification of a permissive epitope insertion site in the vesicular stomatitis virus glycoprotein.

Authors:  Lisa D Schlehuber; John K Rose
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.

Authors:  Xian-Yang Zhang; Robert H Kutner; Agnieszka Bialkowska; Michael P Marino; William B Klimstra; Jakob Reiser
Journal:  Retrovirology       Date:  2010-01-25       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.